Cargando…

Editorial: Research, Development and Clinical Trials for Peptide-Based Vaccines

Detalles Bibliográficos
Autores principales:	Jiang, Shisong, Gong, Min, Xu, Xiao-Ning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9074893/ https://www.ncbi.nlm.nih.gov/pubmed/35529849 http://dx.doi.org/10.3389/fimmu.2022.894989

Ejemplares similares

Editorial: Peptide-based immunotherapy against emerging viral infections
por: Jiang, Shisong
Publicado: (2023)

Beyond Just Peptide Antigens: The Complex World of Peptide-Based Cancer Vaccines
por: Stephens, Alexander J., et al.
Publicado: (2021)

Editorial: Research advances of tuberculosis vaccine and its implication on COVID-19
por: Gong, Wenping, et al.
Publicado: (2023)

Peptide-Based Vaccines for Tuberculosis
por: Gong, Wenping, et al.
Publicado: (2022)

Editorial: Puzzle pieces from malaria vaccine clinical trials
por: Palacpac, Nirianne Marie Q., et al.
Publicado: (2023)

Potential association factors for developing effective peptide-based cancer vaccines
por: Jiang, Chongming, et al.
Publicado: (2022)

In Vitro and In Vivo Antigen Presentation and Diagnosis Development of Recombinant Overlapping Peptides Corresponding to Mtb ESAT-6/CFP-10
por: Zhang, Qing, et al.
Publicado: (2022)

Editorial: Irradiation technologies for vaccine development
por: Wijewardana, Viskam, et al.
Publicado: (2023)

Editorial: Paradigm Changes are Required in HIV Vaccine Research
por: Van Regenmortel, Marc H. V.
Publicado: (2015)

HIV associated cell death: Peptide-induced apoptosis restricts viral transmission
por: Chen, Qiongyu, et al.
Publicado: (2023)

A Neoantigen-Based Peptide Vaccine for Patients With Advanced Pancreatic Cancer Refractory to Standard Treatment
por: Chen, Zheling, et al.
Publicado: (2021)

Editorial: Trained Immunity-Based Vaccines
por: Subiza, Jose Luis, et al.
Publicado: (2021)

Editorial: Frontiers’ Research Topic “Cancer Vaccines: Time to Think Differently!”
por: McArdle, Stephanie E. B., et al.
Publicado: (2021)

Editorial: Immunological Memory to Fungal Infections and Vaccine Development
por: Nicola, André Moraes, et al.
Publicado: (2022)

Recent advance in the development of tuberculosis vaccines in clinical trials and virus-like particle-based vaccine candidates
por: Zhou, Fangbin, et al.
Publicado: (2023)

Anti-dengue Vaccines: From Development to Clinical Trials
por: Pinheiro-Michelsen, Josilene Ramos, et al.
Publicado: (2020)

Peptide-based vaccine for cancer therapies
por: Buonaguro, Luigi, et al.
Publicado: (2023)

Editorial: Approaches to Advance Cancer Vaccines to Clinical Utility
por: Van Nuffel, An M. T., et al.
Publicado: (2019)

Editorial: Reassessing Twenty Years of Vaccine Development against Tuberculosis
por: Schaible, Ulrich E., et al.
Publicado: (2018)

Editorial: Mycobacterial Glycolipids—Role in Immunomodulation and Targets for Vaccine Development
por: Källenius, Gunilla, et al.
Publicado: (2020)

Editorial: Recent advances in the development of vaccines against Acinetobacter baumannii
por: Khalili, Saeed, et al.
Publicado: (2023)

An arginase1- and PD-L1-derived peptide-based vaccine for myeloproliferative neoplasms: A first-in-man clinical trial
por: Grauslund, Jacob Handlos, et al.
Publicado: (2023)

Overlapping synthetic peptides as vaccines
por: Jiang, Shisong, et al.
Publicado: (2006)

Editorial: Contemporary challenges in immunologic testing in clinical and research laboratories
por: Andrade, Luis Eduardo C., et al.
Publicado: (2023)

Research Advances for Virus-vectored Tuberculosis Vaccines and Latest Findings on Tuberculosis Vaccine Development
por: Hu, Zhidong, et al.
Publicado: (2022)

Corrigendum: Peptide-based vaccine for cancer therapies
por: Buonaguro, Luigi, et al.
Publicado: (2023)

Characteristics of clinical trials for non-small cell lung cancer therapeutic vaccines registered on ClinicalTrials.gov
por: Gu, Wenyue, et al.
Publicado: (2022)

Research progress in the development of natural-product-based mucosal vaccine adjuvants
por: Gao, Yingying, et al.
Publicado: (2023)

Editorial: Current Progress and Challenges in the Development of a B Cell Based Hepatitis C Virus Vaccine
por: Foung, Steven K. H., et al.
Publicado: (2018)

Editorial: Syphilis infection: clinical, epidemiology, basic science, and behavioral research
por: Zhou, Pingyu, et al.
Publicado: (2023)

Editorial: Translating NK cell scientific research to clinical product manufacturing
por: Ullrich, Evelyn, et al.
Publicado: (2023)

Editorial: History of Chemoattractant Research
por: Moser, Bernhard
Publicado: (2015)

Editorial: Glycoconjugates in vaccines and immunotherapeutics
por: Shivatare, Sachin, et al.
Publicado: (2022)

Editorial: Antimicrobial Peptides and Complement – Maximising the Inflammatory Response
por: Stover, Cordula M.
Publicado: (2015)

Editorial: Vaccines and Immunostimulants for Finfish
por: Munang'andu, Hetron M., et al.
Publicado: (2020)

Novel Strategies for Peptide-Based Vaccines in Hematological Malignancies
por: Klausen, Uffe, et al.
Publicado: (2018)

Norovirus Vaccine: Priorities for Future Research and Development
por: Esposito, Susanna, et al.
Publicado: (2020)

Comparison of Protein and Peptide Targeting for the Development of a CD169-Based Vaccination Strategy Against Melanoma
por: van Dinther, Dieke, et al.
Publicado: (2018)

Peptide Vaccines for Leishmaniasis
por: De Brito, Rory C. F., et al.
Publicado: (2018)

Editorial: The Clinical Application of Neoantigens
por: Zhou, Jian-Guo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mtfe8n3lf321tvs9m1hne320u4